Art
J-GLOBAL ID:201802283482662168   Reference number:18A0886388

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

転移性大腸癌患者の第一選択治療としてのS-1とイリノテカン併用ベバシズマブ対mFOLFOX6あるいはCapeOX併用ベバシズマブ(TRICOLORE):無作為化非盲検第III相非劣性試験
Author (20):
Material:
Volume: 29  Issue:Page: 624-631  Publication year: Mar. 2018 
JST Material Number: W0107A  ISSN: 0923-7534  CODEN: ANONE2  Document type: Article
Article type: 原著論文  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0886388&from=J-GLOBAL&jstjournalNo=W0107A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Tumors(=neoplasms)of digestive system  ,  Drug therapy(=pharmacotherapy)for tumors 
Substance index (2):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page